DK2322631T3 - Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar - Google Patents

Info

Publication number

DK2322631T3

DK2322631T3 DK10182672.5T DK10182672T DK2322631T3 DK 2322631 T3 DK2322631 T3 DK 2322631T3 DK 10182672 T DK10182672 T DK 10182672T DK 2322631 T3 DK2322631 T3 DK 2322631T3

Authority

DK

Denmark

Prior art keywords

amino acid

amino acids

trna

unnatural amino

protein

Prior art date

2001-04-19

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title description 157
• 239000000203 mixture Substances 0.000 title description 68
• 238000004519 manufacturing process Methods 0.000 title description 34
• 241000588724 Escherichia coli Species 0.000 claims description 56
• 125000003729 nucleotide group Chemical group 0.000 claims description 9
• 239000002773 nucleotide Substances 0.000 claims description 8
• 229940024606 amino acid Drugs 0.000 description 498
• 235000001014 amino acid Nutrition 0.000 description 498
• 150000001413 amino acids Chemical class 0.000 description 498
• 108090000623 proteins and genes Proteins 0.000 description 337
• 102000004169 proteins and genes Human genes 0.000 description 246
• 235000018102 proteins Nutrition 0.000 description 229
• 210000004027 cell Anatomy 0.000 description 215
• 108020004566 Transfer RNA Proteins 0.000 description 153
• 108090000364 Ligases Proteins 0.000 description 137
• 102000003960 Ligases Human genes 0.000 description 133
• 108090000765 processed proteins & peptides Proteins 0.000 description 126
• 108020004705 Codon Proteins 0.000 description 122
• 102000004196 processed proteins & peptides Human genes 0.000 description 108
• 229920001184 polypeptide Polymers 0.000 description 102
• 239000013612 plasmid Substances 0.000 description 89
• 150000007523 nucleic acids Chemical class 0.000 description 76
• 238000010348 incorporation Methods 0.000 description 69
• 102000039446 nucleic acids Human genes 0.000 description 68
• 108020004707 nucleic acids Proteins 0.000 description 68
• 238000001727 in vivo Methods 0.000 description 56
• 108020005038 Terminator Codon Proteins 0.000 description 55
• -1 cyclic glutamine derivative Chemical class 0.000 description 51
• 230000014616 translation Effects 0.000 description 47
• 229960004441 tyrosine Drugs 0.000 description 47
• 102000004190 Enzymes Human genes 0.000 description 44
• 108090000790 Enzymes Proteins 0.000 description 44
• 238000009739 binding Methods 0.000 description 44
• 229940088598 enzyme Drugs 0.000 description 44
• 235000002374 tyrosine Nutrition 0.000 description 44
• 230000027455 binding Effects 0.000 description 43
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 42
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 41
• 230000015572 biosynthetic process Effects 0.000 description 40
• 241000203407 Methanocaldococcus jannaschii Species 0.000 description 39
• 108020004414 DNA Proteins 0.000 description 36
• 238000013519 translation Methods 0.000 description 36
• 108091060545 Nonsense suppressor Proteins 0.000 description 34
• 230000000694 effects Effects 0.000 description 34
• 230000035772 mutation Effects 0.000 description 34
• 229960005091 chloramphenicol Drugs 0.000 description 33
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 33
• 239000003550 marker Substances 0.000 description 33
• 108010022394 Threonine synthase Proteins 0.000 description 32
• 102000004419 dihydrofolate reductase Human genes 0.000 description 32
• 238000000338 in vitro Methods 0.000 description 32
• 238000003786 synthesis reaction Methods 0.000 description 32
• 238000009396 hybridization Methods 0.000 description 30
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 29
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 29
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 28
• 238000002703 mutagenesis Methods 0.000 description 28
• 231100000350 mutagenesis Toxicity 0.000 description 28
• JPZXHKDZASGCLU-LBPRGKRZSA-N β-(2-naphthyl)-alanine Chemical compound C1=CC=CC2=CC(C[C@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-LBPRGKRZSA-N 0.000 description 28
• 230000000875 corresponding effect Effects 0.000 description 27
• 230000002163 immunogen Effects 0.000 description 27
• 238000012360 testing method Methods 0.000 description 27
• 241000894006 Bacteria Species 0.000 description 26
• 238000006467 substitution reaction Methods 0.000 description 26
• 230000001629 suppression Effects 0.000 description 26
• 150000001875 compounds Chemical class 0.000 description 24
• 230000002068 genetic effect Effects 0.000 description 24
• 230000037361 pathway Effects 0.000 description 24
• 239000000523 sample Substances 0.000 description 24
• 239000013598 vector Substances 0.000 description 24
• 231100000331 toxic Toxicity 0.000 description 23
• 230000002588 toxic effect Effects 0.000 description 23
• 125000001493 tyrosinyl group Chemical class [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 23
• 238000002741 site-directed mutagenesis Methods 0.000 description 22
• 238000003556 assay Methods 0.000 description 21
• 239000012634 fragment Substances 0.000 description 21
• 239000000758 substrate Substances 0.000 description 21
• 101710137500 T7 RNA polymerase Proteins 0.000 description 20
• 238000007792 addition Methods 0.000 description 19
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
• 238000004458 analytical method Methods 0.000 description 17
• 230000001851 biosynthetic effect Effects 0.000 description 17
• 238000006243 chemical reaction Methods 0.000 description 17
• 238000009472 formulation Methods 0.000 description 17
• 231100000419 toxicity Toxicity 0.000 description 17
• 230000001988 toxicity Effects 0.000 description 17
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 16
• 125000003275 alpha amino acid group Chemical group 0.000 description 16
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 16
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 16
• 230000006870 function Effects 0.000 description 16
• 238000012216 screening Methods 0.000 description 16
• 230000001225 therapeutic effect Effects 0.000 description 16
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 15
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 15
• 239000002253 acid Substances 0.000 description 15
• 238000013459 approach Methods 0.000 description 15
• 230000000295 complement effect Effects 0.000 description 15
• 239000013078 crystal Substances 0.000 description 15
• 238000002474 experimental method Methods 0.000 description 15
• 239000005090 green fluorescent protein Substances 0.000 description 15
• 230000004044 response Effects 0.000 description 15
• 239000000126 substance Substances 0.000 description 15
• 238000004422 calculation algorithm Methods 0.000 description 14
• 239000003153 chemical reaction reagent Substances 0.000 description 14
• 230000000052 comparative effect Effects 0.000 description 14
• 235000008729 phenylalanine Nutrition 0.000 description 14
• 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 13
• 230000003197 catalytic effect Effects 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 238000000746 purification Methods 0.000 description 13
• 241000196324 Embryophyta Species 0.000 description 12
• 241000588722 Escherichia Species 0.000 description 12
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 12
• 108010062374 Myoglobin Proteins 0.000 description 12
• 150000007513 acids Chemical class 0.000 description 12
• 230000006696 biosynthetic metabolic pathway Effects 0.000 description 12
• 229960002743 glutamine Drugs 0.000 description 12
• 239000006151 minimal media Substances 0.000 description 12
• 229960005190 phenylalanine Drugs 0.000 description 12
• CMUHFUGDYMFHEI-QMMMGPOBSA-N 4-amino-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N)C=C1 CMUHFUGDYMFHEI-QMMMGPOBSA-N 0.000 description 11
• 108020005098 Anticodon Proteins 0.000 description 11
• 108010021466 Mutant Proteins Proteins 0.000 description 11
• 102000008300 Mutant Proteins Human genes 0.000 description 11
• 239000003795 chemical substances by application Substances 0.000 description 11
• 230000001419 dependent effect Effects 0.000 description 11
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 11
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 11
• 235000004554 glutamine Nutrition 0.000 description 11
• 150000002500 ions Chemical class 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 10
• WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 10
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 10
• 102100030856 Myoglobin Human genes 0.000 description 10
• 206010028980 Neoplasm Diseases 0.000 description 10
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 10
• 229960000723 ampicillin Drugs 0.000 description 10
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 10
• WTFXTQVDAKGDEY-HTQZYQBOSA-L chorismate(2-) Chemical compound O[C@@H]1C=CC(C([O-])=O)=C[C@H]1OC(=C)C([O-])=O WTFXTQVDAKGDEY-HTQZYQBOSA-L 0.000 description 10
• 230000012010 growth Effects 0.000 description 10
• 239000001257 hydrogen Substances 0.000 description 10
• 229910052739 hydrogen Inorganic materials 0.000 description 10
• 230000008569 process Effects 0.000 description 10
• 238000001262 western blot Methods 0.000 description 10
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
• DHEJDHPRYHYLKS-UHFFFAOYSA-N 2-(3,6-dihydroxy-9h-xanthen-9-yl)benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 DHEJDHPRYHYLKS-UHFFFAOYSA-N 0.000 description 9
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
• 241000193385 Geobacillus stearothermophilus Species 0.000 description 9
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 9
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 9
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 9
• 230000008901 benefit Effects 0.000 description 9
• 230000010261 cell growth Effects 0.000 description 9
• 238000003018 immunoassay Methods 0.000 description 9
• 238000003780 insertion Methods 0.000 description 9
• 230000037431 insertion Effects 0.000 description 9
• 239000007788 liquid Substances 0.000 description 9
• 239000007787 solid Substances 0.000 description 9
• 239000000243 solution Substances 0.000 description 9
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
• 108700005090 Lethal Genes Proteins 0.000 description 8
• 239000004472 Lysine Substances 0.000 description 8
• 108091028043 Nucleic acid sequence Proteins 0.000 description 8
• 108091034117 Oligonucleotide Proteins 0.000 description 8
• 101150055766 cat gene Proteins 0.000 description 8
• 230000004700 cellular uptake Effects 0.000 description 8
• 238000010276 construction Methods 0.000 description 8
• 238000005516 engineering process Methods 0.000 description 8
• 235000013922 glutamic acid Nutrition 0.000 description 8
• 239000004220 glutamic acid Substances 0.000 description 8
• 235000018977 lysine Nutrition 0.000 description 8
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 8
• 108091033319 polynucleotide Proteins 0.000 description 8
• 102000040430 polynucleotide Human genes 0.000 description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
• 239000003053 toxin Substances 0.000 description 8
• 231100000765 toxin Toxicity 0.000 description 8
• 108700012359 toxins Proteins 0.000 description 8
• XTXGLOBWOMUGQB-VIFPVBQESA-N (2s)-2-azaniumyl-3-(3-methoxyphenyl)propanoate Chemical compound COC1=CC=CC(C[C@H](N)C(O)=O)=C1 XTXGLOBWOMUGQB-VIFPVBQESA-N 0.000 description 7
• IBCKYXVMEMSMQM-JTQLQIEISA-N (2s)-3-(3-acetylphenyl)-2-aminopropanoic acid Chemical compound CC(=O)C1=CC=CC(C[C@H](N)C(O)=O)=C1 IBCKYXVMEMSMQM-JTQLQIEISA-N 0.000 description 7
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 7
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
• 108020004485 Nonsense Codon Proteins 0.000 description 7
• 102000002798 Phenylalanine-tRNA Ligase Human genes 0.000 description 7
• 108010004478 Phenylalanine-tRNA Ligase Proteins 0.000 description 7
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
• 239000004098 Tetracycline Substances 0.000 description 7
• 238000001042 affinity chromatography Methods 0.000 description 7
• 235000004279 alanine Nutrition 0.000 description 7
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 7
• 230000006229 amino acid addition Effects 0.000 description 7
• 125000003118 aryl group Chemical group 0.000 description 7
• 210000004899 c-terminal region Anatomy 0.000 description 7
• 230000009260 cross reactivity Effects 0.000 description 7
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
• 125000000404 glutamine group Chemical class N[C@@H](CCC(N)=O)C(=O)* 0.000 description 7
• 230000002209 hydrophobic effect Effects 0.000 description 7
• 229930027917 kanamycin Natural products 0.000 description 7
• 229960000318 kanamycin Drugs 0.000 description 7
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 7
• 229930182823 kanamycin A Natural products 0.000 description 7
• 235000005772 leucine Nutrition 0.000 description 7
• 238000001819 mass spectrum Methods 0.000 description 7
• 108020004999 messenger RNA Proteins 0.000 description 7
• 150000002994 phenylalanines Chemical class 0.000 description 7
• 239000002953 phosphate buffered saline Substances 0.000 description 7
• 238000001742 protein purification Methods 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 229930101283 tetracycline Natural products 0.000 description 7
• 229960002180 tetracycline Drugs 0.000 description 7
• 235000019364 tetracycline Nutrition 0.000 description 7
• 150000003522 tetracyclines Chemical class 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 108010016626 Dipeptides Proteins 0.000 description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 241000205062 Halobacterium Species 0.000 description 6
• 241000238631 Hexapoda Species 0.000 description 6
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 6
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 6
• 241000531819 Streptomyces venezuelae Species 0.000 description 6
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
• QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 6
• 125000004429 atom Chemical group 0.000 description 6
• 229910052799 carbon Inorganic materials 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 6
• 125000000524 functional group Chemical group 0.000 description 6
• 239000000499 gel Substances 0.000 description 6
• 239000000543 intermediate Substances 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
• 238000003752 polymerase chain reaction Methods 0.000 description 6
• 239000002904 solvent Substances 0.000 description 6
• 125000001424 substituent group Chemical group 0.000 description 6
• 230000035897 transcription Effects 0.000 description 6
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
• 108700028369 Alleles Proteins 0.000 description 5
• 108090000204 Dipeptidase 1 Proteins 0.000 description 5
• 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 5
• 241000233866 Fungi Species 0.000 description 5
• 108060003951 Immunoglobulin Proteins 0.000 description 5
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
• 241001465754 Metazoa Species 0.000 description 5
• 241001442654 Percnon planissimum Species 0.000 description 5
• 101710146427 Probable tyrosine-tRNA ligase, cytoplasmic Proteins 0.000 description 5
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 5
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 5
• 108091032917 Transfer-messenger RNA Proteins 0.000 description 5
• 101710107268 Tyrosine-tRNA ligase, mitochondrial Proteins 0.000 description 5
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical class BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 5
• 238000010367 cloning Methods 0.000 description 5
• 238000004132 cross linking Methods 0.000 description 5
• 230000001186 cumulative effect Effects 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• 230000002255 enzymatic effect Effects 0.000 description 5
• 230000005284 excitation Effects 0.000 description 5
• 230000037433 frameshift Effects 0.000 description 5
• 102000018358 immunoglobulin Human genes 0.000 description 5
• 230000001976 improved effect Effects 0.000 description 5
• 230000003993 interaction Effects 0.000 description 5
• 150000002576 ketones Chemical class 0.000 description 5
• 229910052757 nitrogen Inorganic materials 0.000 description 5
• 231100000252 nontoxic Toxicity 0.000 description 5
• 230000003000 nontoxic effect Effects 0.000 description 5
• 238000002823 phage display Methods 0.000 description 5
• 239000012071 phase Substances 0.000 description 5
• 239000002157 polynucleotide Substances 0.000 description 5
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 5
• 238000002708 random mutagenesis Methods 0.000 description 5
• 230000019491 signal transduction Effects 0.000 description 5
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
• 238000010561 standard procedure Methods 0.000 description 5
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 5
• 230000032258 transport Effects 0.000 description 5
• PEMUHKUIQHFMTH-QMMMGPOBSA-N (2s)-2-amino-3-(4-bromophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(Br)C=C1 PEMUHKUIQHFMTH-QMMMGPOBSA-N 0.000 description 4
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
• PZNQZSRPDOEBMS-QMMMGPOBSA-N 4-iodo-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(I)C=C1 PZNQZSRPDOEBMS-QMMMGPOBSA-N 0.000 description 4
• YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 description 4
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
• 239000004475 Arginine Substances 0.000 description 4
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
• 102100031939 Erythropoietin Human genes 0.000 description 4
• 101100218161 Escherichia coli (strain K12) atpG gene Proteins 0.000 description 4
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 4
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
• 101100278853 Mus musculus Dhfr gene Proteins 0.000 description 4
• 101100082836 Pediococcus acidilactici pedC gene Proteins 0.000 description 4
• 102000035195 Peptidases Human genes 0.000 description 4
• 108091005804 Peptidases Proteins 0.000 description 4
• RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 description 4
• 108010079780 Pristinamycin Proteins 0.000 description 4
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
• 241001518258 Streptomyces pristinaespiralis Species 0.000 description 4
• 102000018378 Tyrosine-tRNA ligase Human genes 0.000 description 4
• 238000009825 accumulation Methods 0.000 description 4
• 150000001408 amides Chemical group 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 239000003242 anti bacterial agent Substances 0.000 description 4
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
• 235000009697 arginine Nutrition 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 230000003115 biocidal effect Effects 0.000 description 4
• 201000011510 cancer Diseases 0.000 description 4
• 238000012217 deletion Methods 0.000 description 4
• 230000037430 deletion Effects 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 239000000539 dimer Substances 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
• 229940126864 fibroblast growth factor Drugs 0.000 description 4
• 238000007429 general method Methods 0.000 description 4
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 238000001802 infusion Methods 0.000 description 4
• 238000009630 liquid culture Methods 0.000 description 4
• 238000004949 mass spectrometry Methods 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 229930182817 methionine Natural products 0.000 description 4
• 235000006109 methionine Nutrition 0.000 description 4
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 101150061305 papC gene Proteins 0.000 description 4
• 150000002993 phenylalanine derivatives Chemical class 0.000 description 4
• 230000000704 physical effect Effects 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 229960003961 pristinamycin Drugs 0.000 description 4
• DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 description 4
• JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 description 4
• 229940002612 prodrug Drugs 0.000 description 4
• 239000000651 prodrug Substances 0.000 description 4
• 239000011541 reaction mixture Substances 0.000 description 4
• 108091008146 restriction endonucleases Proteins 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• 239000004332 silver Substances 0.000 description 4
• 229910052709 silver Inorganic materials 0.000 description 4
• 239000007858 starting material Substances 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 238000006257 total synthesis reaction Methods 0.000 description 4
• QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 238000011179 visual inspection Methods 0.000 description 4
• NEMHIKRLROONTL-QMMMGPOBSA-N (2s)-2-azaniumyl-3-(4-azidophenyl)propanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N=[N+]=[N-])C=C1 NEMHIKRLROONTL-QMMMGPOBSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
• 241000567139 Aeropyrum pernix Species 0.000 description 3
• 241000205042 Archaeoglobus fulgidus Species 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• 239000004971 Cross linker Substances 0.000 description 3
• FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 238000004252 FT/ICR mass spectrometry Methods 0.000 description 3
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 3
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 3
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 3
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 3
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
• 108010063738 Interleukins Proteins 0.000 description 3
• 102000015696 Interleukins Human genes 0.000 description 3
• 102000004310 Ion Channels Human genes 0.000 description 3
• 108090000862 Ion Channels Proteins 0.000 description 3
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• ZKZBPNGNEQAJSX-REOHCLBHSA-N L-selenocysteine Chemical compound [SeH]C[C@H](N)C(O)=O ZKZBPNGNEQAJSX-REOHCLBHSA-N 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 101100462972 Mus musculus Pcdh8 gene Proteins 0.000 description 3
• 208000000112 Myalgia Diseases 0.000 description 3
• 108010079246 OMPA outer membrane proteins Proteins 0.000 description 3
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
• 206010037660 Pyrexia Diseases 0.000 description 3
• 241000205156 Pyrococcus furiosus Species 0.000 description 3
• 241000522615 Pyrococcus horikoshii Species 0.000 description 3
• 102000013275 Somatomedins Human genes 0.000 description 3
• 241000039733 Thermoproteus thermophilus Species 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 108090000340 Transaminases Proteins 0.000 description 3
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 3
• 102100040247 Tumor necrosis factor Human genes 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 235000019647 acidic taste Nutrition 0.000 description 3
• 230000003213 activating effect Effects 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• 239000000556 agonist Substances 0.000 description 3
• 125000000217 alkyl group Chemical group 0.000 description 3
• 235000008206 alpha-amino acids Nutrition 0.000 description 3
• 125000000266 alpha-aminoacyl group Chemical group 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 239000000427 antigen Substances 0.000 description 3
• 108091007433 antigens Proteins 0.000 description 3
• 102000036639 antigens Human genes 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 230000003915 cell function Effects 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 238000012512 characterization method Methods 0.000 description 3
• 229960003920 cocaine Drugs 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
• 241001493065 dsRNA viruses Species 0.000 description 3
• 238000000132 electrospray ionisation Methods 0.000 description 3
• 235000019439 ethyl acetate Nutrition 0.000 description 3
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 238000004128 high performance liquid chromatography Methods 0.000 description 3
• 230000007062 hydrolysis Effects 0.000 description 3
• 238000006460 hydrolysis reaction Methods 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 230000002757 inflammatory effect Effects 0.000 description 3
• 229940047122 interleukins Drugs 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 210000000287 oocyte Anatomy 0.000 description 3
• 239000012044 organic layer Substances 0.000 description 3
• 239000003960 organic solvent Substances 0.000 description 3
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 3
• 229920000570 polyether Polymers 0.000 description 3
• 235000013930 proline Nutrition 0.000 description 3
• 125000001500 prolyl group Chemical class [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
• 230000001915 proofreading effect Effects 0.000 description 3
• 238000001243 protein synthesis Methods 0.000 description 3
• 230000004850 protein–protein interaction Effects 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 238000005215 recombination Methods 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 235000016491 selenocysteine Nutrition 0.000 description 3
• 229940055619 selenocysteine Drugs 0.000 description 3
• ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 3
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 235000008521 threonine Nutrition 0.000 description 3
• 102000014898 transaminase activity proteins Human genes 0.000 description 3
• 108091006106 transcriptional activators Proteins 0.000 description 3
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 3
• 241001515965 unidentified phage Species 0.000 description 3
• 235000014393 valine Nutrition 0.000 description 3
• 238000010626 work up procedure Methods 0.000 description 3
• 238000002424 x-ray crystallography Methods 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
• USEYFCOAPFGKLX-JTQLQIEISA-N 4-Dimethylamino-L-phenylalanine Chemical compound CN(C)C1=CC=C(C[C@H](N)C(O)=O)C=C1 USEYFCOAPFGKLX-JTQLQIEISA-N 0.000 description 2
• OIUJHGOLFKDBSU-HTQZYQBOSA-N 4-amino-4-deoxychorismic acid Chemical compound N[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O OIUJHGOLFKDBSU-HTQZYQBOSA-N 0.000 description 2
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 244000105975 Antidesma platyphyllum Species 0.000 description 2
• 241000238421 Arthropoda Species 0.000 description 2
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
• YOZSEGPJAXTSFZ-ZETCQYMHSA-N Azatyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=N1 YOZSEGPJAXTSFZ-ZETCQYMHSA-N 0.000 description 2
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
• 108010029697 CD40 Ligand Proteins 0.000 description 2
• 102100032937 CD40 ligand Human genes 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 108020002739 Catechol O-methyltransferase Proteins 0.000 description 2
• 102100040999 Catechol O-methyltransferase Human genes 0.000 description 2
• NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
• 108010009685 Cholinergic Receptors Proteins 0.000 description 2
• 108010000898 Chorismate mutase Proteins 0.000 description 2
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
• 241000557626 Corvus corax Species 0.000 description 2
• 241000195493 Cryptophyta Species 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 101000925646 Enterobacteria phage T4 Endolysin Proteins 0.000 description 2
• 239000005770 Eugenol Substances 0.000 description 2
• 102100027286 Fanconi anemia group C protein Human genes 0.000 description 2
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
• 102000005720 Glutathione transferase Human genes 0.000 description 2
• 108010070675 Glutathione transferase Proteins 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 102100034221 Growth-regulated alpha protein Human genes 0.000 description 2
• 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
• 102100021866 Hepatocyte growth factor Human genes 0.000 description 2
• 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 2
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 108090001007 Interleukin-8 Proteins 0.000 description 2
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 2
• 241000209510 Liliopsida Species 0.000 description 2
• 102000003820 Lipoxygenases Human genes 0.000 description 2
• 108090000128 Lipoxygenases Proteins 0.000 description 2
• 101000966481 Mus musculus Dihydrofolate reductase Proteins 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 102000043276 Oncogene Human genes 0.000 description 2
• 102000007079 Peptide Fragments Human genes 0.000 description 2
• 108010033276 Peptide Fragments Proteins 0.000 description 2
• 241000283222 Physeter catodon Species 0.000 description 2
• 239000004721 Polyphenylene oxide Substances 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
• 101000713302 Rattus norvegicus Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 description 2
• 101100273253 Rhizopus niveus RNAP gene Proteins 0.000 description 2
• RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 2
• RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 241000269370 Xenopus <genus> Species 0.000 description 2
• 102000034337 acetylcholine receptors Human genes 0.000 description 2
• 229960001138 acetylsalicylic acid Drugs 0.000 description 2
• 230000009056 active transport Effects 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 230000029936 alkylation Effects 0.000 description 2
• 238000005804 alkylation reaction Methods 0.000 description 2
• BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
• 150000001371 alpha-amino acids Chemical class 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 150000008064 anhydrides Chemical class 0.000 description 2
• 150000001450 anions Chemical class 0.000 description 2
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical class NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
• 229910052794 bromium Inorganic materials 0.000 description 2
• 229940074360 caffeic acid Drugs 0.000 description 2
• 235000004883 caffeic acid Nutrition 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 238000012219 cassette mutagenesis Methods 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000003196 chaotropic effect Effects 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 230000001427 coherent effect Effects 0.000 description 2
• 230000009137 competitive binding Effects 0.000 description 2
• 102000006834 complement receptors Human genes 0.000 description 2
• 108010047295 complement receptors Proteins 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 238000004163 cytometry Methods 0.000 description 2
• 210000000805 cytoplasm Anatomy 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 238000010511 deprotection reaction Methods 0.000 description 2
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
• 235000011180 diphosphates Nutrition 0.000 description 2
• 230000012361 double-strand break repair Effects 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 238000007876 drug discovery Methods 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 238000006911 enzymatic reaction Methods 0.000 description 2
• 229960002217 eugenol Drugs 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 238000002189 fluorescence spectrum Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 235000009424 haa Nutrition 0.000 description 2
• 229940022353 herceptin Drugs 0.000 description 2
• 231100000086 high toxicity Toxicity 0.000 description 2
• 235000014304 histidine Nutrition 0.000 description 2
• 229930195733 hydrocarbon Natural products 0.000 description 2
• 150000002430 hydrocarbons Chemical class 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 229940047124 interferons Drugs 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 229910052740 iodine Inorganic materials 0.000 description 2
• 239000011630 iodine Substances 0.000 description 2
• 238000000534 ion trap mass spectrometry Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
• 231100000053 low toxicity Toxicity 0.000 description 2
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 230000037353 metabolic pathway Effects 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
• 229960000485 methotrexate Drugs 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 238000000520 microinjection Methods 0.000 description 2
• 230000033607 mismatch repair Effects 0.000 description 2
• 231100001224 moderate toxicity Toxicity 0.000 description 2
• 238000001823 molecular biology technique Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 239000013642 negative control Substances 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
• 231100000956 nontoxicity Toxicity 0.000 description 2
• 238000007899 nucleic acid hybridization Methods 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 229940029358 orthoclone okt3 Drugs 0.000 description 2
• 238000012856 packing Methods 0.000 description 2
• 229960005489 paracetamol Drugs 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 108010082406 peptide permease Proteins 0.000 description 2
• VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 2
• 230000029553 photosynthesis Effects 0.000 description 2
• 238000010672 photosynthesis Methods 0.000 description 2
• 229920002401 polyacrylamide Polymers 0.000 description 2
• FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Chemical compound OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 2
• 235000019833 protease Nutrition 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 230000004853 protein function Effects 0.000 description 2
• 238000011158 quantitative evaluation Methods 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 229960004641 rituximab Drugs 0.000 description 2
• 150000003839 salts Chemical class 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 229960002718 selenomethionine Drugs 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 238000001228 spectrum Methods 0.000 description 2
• 108010068698 spleen exonuclease Proteins 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 108010074429 thiolsubtilisins Proteins 0.000 description 2
• 238000002723 toxicity assay Methods 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 230000004614 tumor growth Effects 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• KNWCDYSKJSREAQ-VKHMYHEASA-N (2s)-1,3-oxazolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1NCCO1 KNWCDYSKJSREAQ-VKHMYHEASA-N 0.000 description 1
• FQRURPFZTFUXEZ-MRVPVSSYSA-N (2s)-2,3,3,3-tetrafluoro-2-(n-fluoroanilino)propanoic acid Chemical compound OC(=O)[C@](F)(C(F)(F)F)N(F)C1=CC=CC=C1 FQRURPFZTFUXEZ-MRVPVSSYSA-N 0.000 description 1
• VKBLQCDGTHFOLS-NSHDSACASA-N (2s)-2-(4-benzoylanilino)propanoic acid Chemical compound C1=CC(N[C@@H](C)C(O)=O)=CC=C1C(=O)C1=CC=CC=C1 VKBLQCDGTHFOLS-NSHDSACASA-N 0.000 description 1
• RWLSBXBFZHDHHX-VIFPVBQESA-N (2s)-2-(naphthalen-2-ylamino)propanoic acid Chemical compound C1=CC=CC2=CC(N[C@@H](C)C(O)=O)=CC=C21 RWLSBXBFZHDHHX-VIFPVBQESA-N 0.000 description 1
• YYTDJPUFAVPHQA-VKHMYHEASA-N (2s)-2-amino-3-(2,3,4,5,6-pentafluorophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=C(F)C(F)=C(F)C(F)=C1F YYTDJPUFAVPHQA-VKHMYHEASA-N 0.000 description 1
• AXEOMQHKTSGLGS-VIFPVBQESA-N (2s)-2-amino-3-(4-hydroxy-2-methylphenyl)propanoic acid Chemical compound CC1=CC(O)=CC=C1C[C@H](N)C(O)=O AXEOMQHKTSGLGS-VIFPVBQESA-N 0.000 description 1
• BEWCSNDRHAIGAY-BYPYZUCNSA-N (2s)-2-amino-4-methyltellanylbutanoic acid Chemical compound C[Te]CC[C@H](N)C(O)=O BEWCSNDRHAIGAY-BYPYZUCNSA-N 0.000 description 1
• CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 1
• BNIFSVVAHBLNTN-XKKUQSFHSA-N (2s)-4-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-4-amino-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexan Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O)CCC1 BNIFSVVAHBLNTN-XKKUQSFHSA-N 0.000 description 1
• 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
• WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
• FIBWYNMFIDOWTC-UHFFFAOYSA-N 1-[3-(2-bromoethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CCBr)=C1 FIBWYNMFIDOWTC-UHFFFAOYSA-N 0.000 description 1
• TZVOWUZAOVUUBP-UHFFFAOYSA-N 1-[3-(bromomethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(CBr)=C1 TZVOWUZAOVUUBP-UHFFFAOYSA-N 0.000 description 1
• 238000005160 1H NMR spectroscopy Methods 0.000 description 1
• HKAVADYDPYUPRD-UHFFFAOYSA-N 1h-pyrazine-2-thione Chemical compound SC1=CN=CC=N1 HKAVADYDPYUPRD-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
• IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
• SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
• HWDZIRSKXFAMFU-UHFFFAOYSA-N 3-(4-aminophenyl)pyruvic acid Chemical compound NC1=CC=C(CC(=O)C(O)=O)C=C1 HWDZIRSKXFAMFU-UHFFFAOYSA-N 0.000 description 1
• JZRBSTONIYRNRI-VIFPVBQESA-N 3-methylphenylalanine Chemical compound CC1=CC=CC(C[C@H](N)C(O)=O)=C1 JZRBSTONIYRNRI-VIFPVBQESA-N 0.000 description 1
• IRZQDMYEJPNDEN-UHFFFAOYSA-N 3-phenyl-2-aminobutanoic acid Natural products OC(=O)C(N)C(C)C1=CC=CC=C1 IRZQDMYEJPNDEN-UHFFFAOYSA-N 0.000 description 1
• ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical group C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
• YXDGRBPZVQPESQ-QMMMGPOBSA-N 4-[(2s)-2-amino-2-carboxyethyl]benzoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(C(O)=O)C=C1 YXDGRBPZVQPESQ-QMMMGPOBSA-N 0.000 description 1
• OJJQTAMHYLSXHT-UHFFFAOYSA-N 4-amino-1-(2-carboxy-2-oxoethyl)cyclohexa-2,5-diene-1-carboxylic acid Chemical compound NC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 OJJQTAMHYLSXHT-UHFFFAOYSA-N 0.000 description 1
• XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical class OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
• XWHHYOYVRVGJJY-UHFFFAOYSA-N 4-fluorophenylalanine Chemical compound OC(=O)C(N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-UHFFFAOYSA-N 0.000 description 1
• 108020003589 5' Untranslated Regions Proteins 0.000 description 1
• XFGVJLGVINCWDP-UHFFFAOYSA-N 5,5,5-trifluoroleucine Chemical compound FC(F)(F)C(C)CC(N)C(O)=O XFGVJLGVINCWDP-UHFFFAOYSA-N 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• HYQXNCDBSALQLB-UHFFFAOYSA-N 9-bromo-9-phenylfluorene Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1(Br)C1=CC=CC=C1 HYQXNCDBSALQLB-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
• PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
• 108700023418 Amidases Proteins 0.000 description 1
• 102000004092 Amidohydrolases Human genes 0.000 description 1
• 108090000531 Amidohydrolases Proteins 0.000 description 1
• 108050005273 Amino acid transporters Proteins 0.000 description 1
• 102000034263 Amino acid transporters Human genes 0.000 description 1
• 108010052434 Aminodeoxychorismate synthase Proteins 0.000 description 1
• 102400000068 Angiostatin Human genes 0.000 description 1
• 108010079709 Angiostatins Proteins 0.000 description 1
• 102000007592 Apolipoproteins Human genes 0.000 description 1
• 108010071619 Apolipoproteins Proteins 0.000 description 1
• 108010083590 Apoproteins Proteins 0.000 description 1
• 102000006410 Apoproteins Human genes 0.000 description 1
• OZDNDGXASTWERN-CTNGQTDRSA-N Apovincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-CTNGQTDRSA-N 0.000 description 1
• 101000716807 Arabidopsis thaliana Protein SCO1 homolog 1, mitochondrial Proteins 0.000 description 1
• 101000787278 Arabidopsis thaliana Valine-tRNA ligase, chloroplastic/mitochondrial 2 Proteins 0.000 description 1
• 101000787296 Arabidopsis thaliana Valine-tRNA ligase, mitochondrial 1 Proteins 0.000 description 1
• 241000203069 Archaea Species 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• 208000002109 Argyria Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 101800001288 Atrial natriuretic factor Proteins 0.000 description 1
• 102400001282 Atrial natriuretic peptide Human genes 0.000 description 1
• 101800001890 Atrial natriuretic peptide Proteins 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 206010055113 Breast cancer metastatic Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
• 102100036150 C-X-C motif chemokine 5 Human genes 0.000 description 1
• 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 1
• 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 1
• 102000001902 CC Chemokines Human genes 0.000 description 1
• 108010040471 CC Chemokines Proteins 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 108050006947 CXC Chemokine Proteins 0.000 description 1
• 102000019388 CXC chemokine Human genes 0.000 description 1
• 101100479039 Caenorhabditis elegans aars-1 gene Proteins 0.000 description 1
• 101100392772 Caenorhabditis elegans gln-2 gene Proteins 0.000 description 1
• 102000055006 Calcitonin Human genes 0.000 description 1
• 108060001064 Calcitonin Proteins 0.000 description 1
• 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 102000005367 Carboxypeptidases Human genes 0.000 description 1
• 108010006303 Carboxypeptidases Proteins 0.000 description 1
• 102000000496 Carboxypeptidases A Human genes 0.000 description 1
• 108010080937 Carboxypeptidases A Proteins 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
• 102000052603 Chaperonins Human genes 0.000 description 1
• 108010055166 Chemokine CCL5 Proteins 0.000 description 1
• 108010055124 Chemokine CCL7 Proteins 0.000 description 1
• 102000000012 Chemokine CCL8 Human genes 0.000 description 1
• 108010055204 Chemokine CCL8 Proteins 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 101710123154 Chloramphenicol resistance protein Proteins 0.000 description 1
• 108010003662 Chorismate synthase Proteins 0.000 description 1
• 241000219930 Clarkia Species 0.000 description 1
• 102100022641 Coagulation factor IX Human genes 0.000 description 1
• 102100023804 Coagulation factor VII Human genes 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 229940124073 Complement inhibitor Drugs 0.000 description 1
• 102100031673 Corneodesmosin Human genes 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
• 101000702579 Crotalus durissus terrificus Snaclec crotocetin Proteins 0.000 description 1
• 102100026398 Cyclic AMP-responsive element-binding protein 3 Human genes 0.000 description 1
• QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• 229930195713 D-glutamate Natural products 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 108010017826 DNA Polymerase I Proteins 0.000 description 1
• 102000004594 DNA Polymerase I Human genes 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 206010012335 Dependence Diseases 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 101000787280 Dictyostelium discoideum Probable valine-tRNA ligase, mitochondrial Proteins 0.000 description 1
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
• 102000016680 Dioxygenases Human genes 0.000 description 1
• 108010028143 Dioxygenases Proteins 0.000 description 1
• 101710196859 Dipeptide-binding protein Proteins 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 101150029707 ERBB2 gene Proteins 0.000 description 1
• 241000224431 Entamoeba Species 0.000 description 1
• 101710104662 Enterotoxin type C-3 Proteins 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 108010092408 Eosinophil Peroxidase Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 108020002908 Epoxide hydrolase Proteins 0.000 description 1
• 102000005486 Epoxide hydrolase Human genes 0.000 description 1
• 241001125671 Eretmochelys imbricata Species 0.000 description 1
• 241000402754 Erythranthe moschata Species 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 241001452028 Escherichia coli DH1 Species 0.000 description 1
• 101900234631 Escherichia coli DNA polymerase I Proteins 0.000 description 1
• 241000701533 Escherichia virus T4 Species 0.000 description 1
• 108090000371 Esterases Proteins 0.000 description 1
• 241000186394 Eubacterium Species 0.000 description 1
• 102100030844 Exocyst complex component 1 Human genes 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 108010076282 Factor IX Proteins 0.000 description 1
• 108010023321 Factor VII Proteins 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 108010014173 Factor X Proteins 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 241000724791 Filamentous phage Species 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 102000034286 G proteins Human genes 0.000 description 1
• 108091006027 G proteins Proteins 0.000 description 1
• 102100040837 Galactoside alpha-(1,2)-fucosyltransferase 2 Human genes 0.000 description 1
• 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
• 241000224466 Giardia Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102000004547 Glucosylceramidase Human genes 0.000 description 1
• 108010017544 Glucosylceramidase Proteins 0.000 description 1
• 102100024977 Glutamine-tRNA ligase Human genes 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010053070 Glutathione Disulfide Proteins 0.000 description 1
• 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
• 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
• 108700023372 Glycosyltransferases Proteins 0.000 description 1
• 108010086677 Gonadotropins Proteins 0.000 description 1
• 102000006771 Gonadotropins Human genes 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 108010010369 HIV Protease Proteins 0.000 description 1
• 108090000031 Hedgehog Proteins Proteins 0.000 description 1
• 102000003693 Hedgehog Proteins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 102000007625 Hirudins Human genes 0.000 description 1
• 108010007267 Hirudins Proteins 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000855520 Homo sapiens Cyclic AMP-responsive element-binding protein 3 Proteins 0.000 description 1
• 101000893710 Homo sapiens Galactoside alpha-(1,2)-fucosyltransferase 2 Proteins 0.000 description 1
• 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 description 1
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 1
• 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
• 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 description 1
• 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 1
• 101001076715 Homo sapiens RNA-binding protein 39 Proteins 0.000 description 1
• 101000652229 Homo sapiens Suppressor of cytokine signaling 7 Proteins 0.000 description 1
• 206010062904 Hormone-refractory prostate cancer Diseases 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 108010058683 Immobilized Proteins Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 108010008212 Integrin alpha4beta1 Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 1
• 108090000769 Isomerases Proteins 0.000 description 1
• 102000004195 Isomerases Human genes 0.000 description 1
• 229930194542 Keto Chemical class 0.000 description 1
• 102100020880 Kit ligand Human genes 0.000 description 1
• 101710177504 Kit ligand Proteins 0.000 description 1
• 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
• 235000014852 L-arginine Nutrition 0.000 description 1
• 229930064664 L-arginine Natural products 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• JZKXXXDKRQWDET-QMMMGPOBSA-N L-m-tyrosine Chemical class OC(=O)[C@@H](N)CC1=CC=CC(O)=C1 JZKXXXDKRQWDET-QMMMGPOBSA-N 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
• 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108010001831 LDL receptors Proteins 0.000 description 1
• 108010063045 Lactoferrin Proteins 0.000 description 1
• 102000010445 Lactoferrin Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 108010054320 Lignin peroxidase Proteins 0.000 description 1
• 101710155614 Ligninase A Proteins 0.000 description 1
• 101710155621 Ligninase B Proteins 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
• 108010003060 Methionine-tRNA ligase Proteins 0.000 description 1
• 102000000362 Methionyl-tRNA synthetases Human genes 0.000 description 1
• 238000006845 Michael addition reaction Methods 0.000 description 1
• 241000191938 Micrococcus luteus Species 0.000 description 1
• 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
• 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
• 231100000678 Mycotoxin Toxicity 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 108010040722 Neurokinin-2 Receptors Proteins 0.000 description 1
• 108010015406 Neurturin Proteins 0.000 description 1
• 102000001839 Neurturin Human genes 0.000 description 1
• 108010033272 Nitrilase Proteins 0.000 description 1
• 108010024026 Nitrile hydratase Proteins 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 102000004140 Oncostatin M Human genes 0.000 description 1
• 108090000630 Oncostatin M Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 241000713112 Orthobunyavirus Species 0.000 description 1
• 241000702244 Orthoreovirus Species 0.000 description 1
• 108090000417 Oxygenases Proteins 0.000 description 1
• 102000004020 Oxygenases Human genes 0.000 description 1
• PEMUHKUIQHFMTH-UHFFFAOYSA-N P-Bromo-DL-phenylalanine Chemical compound OC(=O)C(N)CC1=CC=C(Br)C=C1 PEMUHKUIQHFMTH-UHFFFAOYSA-N 0.000 description 1
• 238000009004 PCR Kit Methods 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 239000002033 PVDF binder Substances 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 102000003982 Parathyroid hormone Human genes 0.000 description 1
• 108090000445 Parathyroid hormone Proteins 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108010064851 Plant Proteins Proteins 0.000 description 1
• 102100036154 Platelet basic protein Human genes 0.000 description 1
• 102100030304 Platelet factor 4 Human genes 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 102000017033 Porins Human genes 0.000 description 1
• 108010013381 Porins Proteins 0.000 description 1
• 108010035004 Prephenate Dehydrogenase Proteins 0.000 description 1
• 102220477048 Protein C-ets-1_F130S_mutation Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 229940096437 Protein S Drugs 0.000 description 1
• 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
• 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
• 244000184734 Pyrus japonica Species 0.000 description 1
• ASNFTDCKZKHJSW-REOHCLBHSA-N Quisqualic acid Chemical class OC(=O)[C@@H](N)CN1OC(=O)NC1=O ASNFTDCKZKHJSW-REOHCLBHSA-N 0.000 description 1
• 101150015069 RNAP gene Proteins 0.000 description 1
• 108090001066 Racemases and epimerases Proteins 0.000 description 1
• 102000004879 Racemases and epimerases Human genes 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 102000003743 Relaxin Human genes 0.000 description 1
• 108090000103 Relaxin Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 102000002278 Ribosomal Proteins Human genes 0.000 description 1
• 108010000605 Ribosomal Proteins Proteins 0.000 description 1
• 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
• 102100023361 SAP domain-containing ribonucleoprotein Human genes 0.000 description 1
• 101710194492 SET-binding protein Proteins 0.000 description 1
• 241000242678 Schistosoma Species 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 108010051611 Signal Recognition Particle Proteins 0.000 description 1
• 102000013598 Signal recognition particle Human genes 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 108010056088 Somatostatin Proteins 0.000 description 1
• 102000005157 Somatostatin Human genes 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 101000882406 Staphylococcus aureus Enterotoxin type C-1 Proteins 0.000 description 1
• 101000882403 Staphylococcus aureus Enterotoxin type C-2 Proteins 0.000 description 1
• 101001057112 Staphylococcus aureus Enterotoxin type D Proteins 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 108010023197 Streptokinase Proteins 0.000 description 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 description 1
• 108090000787 Subtilisin Proteins 0.000 description 1
• 108010056079 Subtilisins Proteins 0.000 description 1
• 102000005158 Subtilisins Human genes 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 102100030529 Suppressor of cytokine signaling 7 Human genes 0.000 description 1
• 102000003141 Tachykinin Human genes 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 108010078233 Thymalfasin Proteins 0.000 description 1
• 102400000800 Thymosin alpha-1 Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 206010044248 Toxic shock syndrome Diseases 0.000 description 1
• 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102000006612 Transducin Human genes 0.000 description 1
• 108010087042 Transducin Proteins 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 241000224526 Trichomonas Species 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100025336 Tyrosine-tRNA ligase, mitochondrial Human genes 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 102000013625 Valine-tRNA Ligase Human genes 0.000 description 1
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 102100035140 Vitronectin Human genes 0.000 description 1
• 108700040099 Xylose isomerases Proteins 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 230000004308 accommodation Effects 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229960002478 aldosterone Drugs 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 150000001345 alkine derivatives Chemical group 0.000 description 1
• 150000001351 alkyl iodides Chemical class 0.000 description 1
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
• 102000005922 amidase Human genes 0.000 description 1
• 229940093740 amino acid and derivative Drugs 0.000 description 1
• 229940067621 aminobutyrate Drugs 0.000 description 1
• 229940124277 aminobutyric acid Drugs 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 239000003708 ampul Substances 0.000 description 1
• 230000003698 anagen phase Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000002587 anti-hemolytic effect Effects 0.000 description 1
• 230000001754 anti-pyretic effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 108010082685 antiarrhythmic peptide Proteins 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 229940125715 antihistaminic agent Drugs 0.000 description 1
• 239000000739 antihistaminic agent Substances 0.000 description 1
• 239000003430 antimalarial agent Substances 0.000 description 1
• 229940033495 antimalarials Drugs 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 239000002221 antipyretic Substances 0.000 description 1
• 229940125716 antipyretic agent Drugs 0.000 description 1
• OZDNDGXASTWERN-UHFFFAOYSA-N apovincamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-UHFFFAOYSA-N 0.000 description 1
• 239000012062 aqueous buffer Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 108700003859 araC Genes Proteins 0.000 description 1
• 101150044616 araC gene Proteins 0.000 description 1
• 239000012300 argon atmosphere Substances 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
• 230000001746 atrial effect Effects 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 230000003385 bacteriostatic effect Effects 0.000 description 1
• 238000007630 basic procedure Methods 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 229940000635 beta-alanine Drugs 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 102000006635 beta-lactamase Human genes 0.000 description 1
• 108010002833 beta-lactamase TEM-1 Proteins 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 150000001615 biotins Chemical class 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 239000012267 brine Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 102220377136 c.10C>A Human genes 0.000 description 1
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
• 229960004015 calcitonin Drugs 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
• 150000003857 carboxamides Chemical class 0.000 description 1
• NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 1
• 238000005277 cation exchange chromatography Methods 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000009134 cell regulation Effects 0.000 description 1
• 230000007541 cellular toxicity Effects 0.000 description 1
• 239000003610 charcoal Substances 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 230000000723 chemosensory effect Effects 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 229960003677 chloroquine Drugs 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 230000001332 colony forming effect Effects 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 239000004074 complement inhibitor Substances 0.000 description 1
• 229940125782 compound 2 Drugs 0.000 description 1
• 229940126214 compound 3 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 238000002591 computed tomography Methods 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000011443 conventional therapy Methods 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 239000002254 cytotoxic agent Substances 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000006324 decarbonylation Effects 0.000 description 1
• 238000006606 decarbonylation reaction Methods 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000000593 degrading effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000001784 detoxification Methods 0.000 description 1
• 229950006137 dexfosfoserine Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• ISOLMABRZPQKOV-UHFFFAOYSA-N diethyl 2-acetamidopropanedioate Chemical compound CCOC(=O)C(NC(C)=O)C(=O)OCC ISOLMABRZPQKOV-UHFFFAOYSA-N 0.000 description 1
• 108020001096 dihydrofolate reductase Proteins 0.000 description 1
• 229960000520 diphenhydramine Drugs 0.000 description 1
• 239000002934 diuretic Substances 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 241001492478 dsDNA viruses, no RNA stage Species 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000007247 enzymatic mechanism Effects 0.000 description 1
• 230000009144 enzymatic modification Effects 0.000 description 1
• 230000009483 enzymatic pathway Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• PHTXVQQRWJXYPP-UHFFFAOYSA-N ethyltrifluoromethylaminoindane Chemical compound C1=C(C(F)(F)F)C=C2CC(NCC)CC2=C1 PHTXVQQRWJXYPP-UHFFFAOYSA-N 0.000 description 1
• 241001233957 eudicotyledons Species 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 239000002095 exotoxin Substances 0.000 description 1
• 231100000776 exotoxin Toxicity 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 230000004438 eyesight Effects 0.000 description 1
• 229960004222 factor ix Drugs 0.000 description 1
• 229940012413 factor vii Drugs 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 229940012426 factor x Drugs 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 238000009093 first-line therapy Methods 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
• ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 238000010441 gene drive Methods 0.000 description 1
• 238000012248 genetic selection Methods 0.000 description 1
• 150000002308 glutamine derivatives Chemical class 0.000 description 1
• 108010051239 glutaminyl-tRNA synthetase Proteins 0.000 description 1
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
• 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
• 239000002622 gonadotropin Substances 0.000 description 1
• 239000011544 gradient gel Substances 0.000 description 1
• 125000001475 halogen functional group Chemical group 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 238000013537 high throughput screening Methods 0.000 description 1
• 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
• WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
• 229940006607 hirudin Drugs 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 150000002411 histidines Chemical class 0.000 description 1
• 239000000710 homodimer Substances 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 150000007857 hydrazones Chemical class 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 238000005286 illumination Methods 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 150000002466 imines Chemical class 0.000 description 1
• 150000007976 iminium ions Chemical class 0.000 description 1
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000010324 immunological assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 210000003000 inclusion body Anatomy 0.000 description 1
• 239000003262 industrial enzyme Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 239000002198 insoluble material Substances 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 102000002467 interleukin receptors Human genes 0.000 description 1
• 108010093036 interleukin receptors Proteins 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000005040 ion trap Methods 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 125000000468 ketone group Chemical class 0.000 description 1
• CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 229940078795 lactoferrin Drugs 0.000 description 1
• 235000021242 lactoferrin Nutrition 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 239000012160 loading buffer Substances 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• FSPSELPMWGWDRY-UHFFFAOYSA-N m-Methylacetophenone Chemical compound CC(=O)C1=CC=CC(C)=C1 FSPSELPMWGWDRY-UHFFFAOYSA-N 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 150000002741 methionine derivatives Chemical class 0.000 description 1
• 150000004702 methyl esters Chemical group 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 238000000329 molecular dynamics simulation Methods 0.000 description 1
• 231100000219 mutagenic Toxicity 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 239000002636 mycotoxin Substances 0.000 description 1
• 230000001452 natriuretic effect Effects 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 239000012038 nucleophile Substances 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 230000002188 osteogenic effect Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
• PSWJVKKJYCAPTI-UHFFFAOYSA-N oxido-oxo-phosphonophosphanylphosphanium Chemical compound OP(O)(=O)PP(=O)=O PSWJVKKJYCAPTI-UHFFFAOYSA-N 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• TVIDEEHSOPHZBR-AWEZNQCLSA-N para-(benzoyl)-phenylalanine Chemical compound C1=CC(C[C@H](N)C(O)=O)=CC=C1C(=O)C1=CC=CC=C1 TVIDEEHSOPHZBR-AWEZNQCLSA-N 0.000 description 1
• 239000000199 parathyroid hormone Substances 0.000 description 1
• 229960001319 parathyroid hormone Drugs 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 108010012038 peptide 78 Proteins 0.000 description 1
• 229940125863 peptide 78 Drugs 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 229960000482 pethidine Drugs 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 229940080469 phosphocellulose Drugs 0.000 description 1
• DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000007539 photo-oxidation reaction Methods 0.000 description 1
• XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
• 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000008635 plant growth Effects 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 108010025221 plasma protein Z Proteins 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 102000005162 pleiotrophin Human genes 0.000 description 1
• 230000001402 polyadenylating effect Effects 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 108010080502 preprolactin Proteins 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 239000001294 propane Substances 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 208000023958 prostate neoplasm Diseases 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000006916 protein interaction Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 238000001814 protein method Methods 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• 230000030788 protein refolding Effects 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 230000001698 pyrogenic effect Effects 0.000 description 1
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 239000006176 redox buffer Substances 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 238000000611 regression analysis Methods 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003014 reinforcing effect Effects 0.000 description 1
• 238000009877 rendering Methods 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 125000006853 reporter group Chemical group 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000025600 response to UV Effects 0.000 description 1
• 230000032537 response to toxin Effects 0.000 description 1
• 108010066533 ribonuclease S Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 210000004358 rod cell outer segment Anatomy 0.000 description 1
• 102200024032 rs369610897 Human genes 0.000 description 1
• 102220046326 rs587782837 Human genes 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• QSHGUCSTWRSQAF-FJSLEGQWSA-N s-peptide Chemical group C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C1=CC=C(OS(O)(=O)=O)C=C1 QSHGUCSTWRSQAF-FJSLEGQWSA-N 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• 238000003345 scintillation counting Methods 0.000 description 1
• 230000024053 secondary metabolic process Effects 0.000 description 1
• 229930000044 secondary metabolite Natural products 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 150000003354 serine derivatives Chemical class 0.000 description 1
• 101150091813 shfl gene Proteins 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
• 230000003381 solubilizing effect Effects 0.000 description 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
• 229960000553 somatostatin Drugs 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 102000005969 steroid hormone receptors Human genes 0.000 description 1
• 108020003113 steroid hormone receptors Proteins 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 229960005202 streptokinase Drugs 0.000 description 1
• 125000003107 substituted aryl group Chemical group 0.000 description 1
• 150000003462 sulfoxides Chemical class 0.000 description 1
• 231100000617 superantigen Toxicity 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 108060008037 tachykinin Proteins 0.000 description 1
• 238000004885 tandem mass spectrometry Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 229940126622 therapeutic monoclonal antibody Drugs 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 description 1
• NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 description 1
• 229960004231 thymalfasin Drugs 0.000 description 1
• 239000003734 thymidylate synthase inhibitor Substances 0.000 description 1
• 229950001139 timonacic Drugs 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• YLJLTSVBCXYTQK-VKHMYHEASA-N trifluoro-L-methionine Chemical compound OC(=O)[C@@H](N)CCSC(F)(F)F YLJLTSVBCXYTQK-VKHMYHEASA-N 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
• 238000013024 troubleshooting Methods 0.000 description 1
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
• 150000003667 tyrosine derivatives Chemical class 0.000 description 1
• MJZAZMKENKZBAJ-NEYKFGMSSA-N tyrosyladenylate Chemical compound C([C@H](N)C(=O)NS(=O)(=O)OC[C@H]1[C@@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)O)C1=CC=C(O)C=C1 MJZAZMKENKZBAJ-NEYKFGMSSA-N 0.000 description 1
• 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
• 238000002211 ultraviolet spectrum Methods 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 229960005356 urokinase Drugs 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 150000003680 valines Chemical class 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1